In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population

被引:11
作者
Gwee, Kok-Ann [1 ]
Hwang, Joel Ern-Huei [1 ]
Ho, Khek-Yu [1 ]
Yeoh, Khay-Guan [1 ]
Lum, Chun-Fatt [1 ]
Ang, Poh-Kit [1 ]
机构
[1] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore
关键词
proton pump inhibitor; irritable bowel syndrome; primary care; gastroesophageal reflux; dyspepsia; bloating;
D O I
10.1097/01.mcg.0000225620.02094.c3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Data on Asian patients who present to primary care physicians with dyspepsia are limited. Aim: To determine predictors of response to a trial of proton pump inhibitor therapy. Method.: One hundred ninety patients presenting to their general practitioners with dyspeptic symptoms but without alarm symptoms, underwent endoscopy and were subsequently treated with 20 mg of esomeprazole twice a day for 2 weeks. Possible predictors of response were assessed before treatment. Dyspeptic symptoms were scored at baseline and at the end of treatment. Excellent response and poor response were defined as end A treatment score of <= 1 and failure to achieve >= 50% reduction in symptom scores. Results: On bivariate analysis male sex and having <= 2 concurrent dyspeptic symptoms predicted excellent response, whereas bloating as most bothersome symptom, > 2 dyspeptic symptoms, anxiety, and irritable bowel syndrome predicted poor response. On multivariate analysis, male sex and <= 2 dyspeptic symptoms, and bloating remained significant predictors of excellent and poor responses, respectively. Conclusions: Predictors of response to proton pump inhibitor trial that could be easily assessed in a primary care clinic were identified. In our population the response was not as favorable as suggested by clinical trials. Frequent overlap with irritable bowel syndrome seems to be an important factor.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 21 条
[1]   Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? [J].
Bolling-Sternevald, E ;
Lauritsen, K ;
Talley, NJ ;
Junghard, O ;
Glise, H .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) :117-124
[2]   Effect of profound acid suppression in functional dyspepsia:: a double-blind, randomized, placebo-controlled trial [J].
Bolling-Sternevald, E ;
Lauritsen, K ;
Aalykke, C ;
Havelund, T ;
Knudsen, T ;
Unge, P ;
Ekström, P ;
Jaup, B ;
Norrby, A ;
Stubberöd, A ;
Melén, K ;
Carlsson, R ;
Jerndal, P ;
Junghard, O ;
Glise, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (12) :1395-1402
[3]   Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia [J].
Corsetti, M ;
Caenepeel, P ;
Fischler, B ;
Janssens, J ;
Tack, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (06) :1152-1159
[4]  
Fennerty MB, 2002, GUT, V50, P63
[5]   The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community [J].
Gwee, KA ;
Wee, S ;
Wong, ML ;
Png, DJC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (05) :924-931
[6]   Irritable bowel syndrome in developing countries - a disorder of civilization or colonization? [J].
Gwee, KA .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (03) :317-324
[7]  
Ho KY, 1998, AM J GASTROENTEROL, V93, P1816, DOI 10.1111/j.1572-0241.1998.00526.x
[8]   Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore [J].
Kang, JY ;
Ho, KY .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (08) :845-850
[9]   SYMPTOMS IN GASTROESOPHAGEAL REFLUX DISEASE [J].
KLAUSER, AG ;
SCHINDLBECK, NE ;
MULLERLISSNER, SA .
LANCET, 1990, 335 (8683) :205-208
[10]   Origin of gas retention and symptoms in patients with bloating [J].
Salvioli, B ;
Serra, J ;
Azpiroz, F ;
Lorenzo, C ;
Aguade, S ;
Castell, J ;
Malagelada, JR .
GASTROENTEROLOGY, 2005, 128 (03) :574-579